ライフサイエンスコーパス: meet

1 en the assumptions of WQS regression are not met.

2 response pathway to consequently facilitate MET.

3 the micronutrient needs of both parties are met.

4 d pharmacologic (crizotinib) inhibition of c-MET.

5 All prespecified endpoints were met.

6 lled by epidermal growth factor receptor and MET.

7 the molecular/subcellular and systems levels meet.

8 Three key recommendations emerged from the meeting.

9 s recipients, and presenters at the national meeting.

10 Cez) binds Lys(11)-, Lys(48)-, Lys(63)-, and Met(1)-linked ubiquitin chains in vitro, establishing UB

11 We pinpointed Met-1669 as the residue in the GBA motif of DAPLE that d

12 ionally enhanced mealworms supplied daily to meet 40%-50% of each supplemented brood's food requireme

13 For S-(11)C-methyl)-l-methionine ((11)C-MET) (8 studies, 151 lesions), sensitivity was 93% (95%

14 ants with new wind, solar, or natural gas to meet a CO(2) reduction target in the United States.

15 ression model, and to select predictors that meet a priori specified significance level.

16 y present in our daily life because they can meet a wide range of needs and fields of applications.

17 At the 2019 Annual Meeting, a mere 8 institutions accounted for a dispropor

18 The primary endpoint was met: ACR20 at week 24 was achieved by significantly grea

19 riptomic information, we showed that Prima-1(Met) activity was independent of its canonical target, m

20 Thirty-three percent of LLD participants met ADNI criteria for mild cognitive impairment.

21 ual care group, on further scrutiny, did not meet all eligibility criteria or withdrew from the study

22 have developed a CRISPR-based assay that can meet all these criteria.

23 has a hydraulics-based penalty function that meets all seven criteria and demonstrates a highly predi

24 Overall, 70.2% of e-consults met all 4 criteria for appropriateness; the frequency of

25 One hundred thirty-three controls met all criteria at an outpatient encounter.

26 of the 34 articles selected for full review met all inclusion criteria for this assessment.

27 Of these, 1750 (65%) met all of the eligibility criteria on telephone screeni

28 of MET tyrosine kinase inhibitors varies by MET alteration category.

29 of detecting genomic alterations, high-level MET amplification and activating MET mutations or fusion

30 tentially druggable genetic alterations, and MET amplification was associated with complete tumor res

31 ts and all patients with centrally confirmed MET amplification.

32 years) with locally advanced or metastatic, MET-amplified, EGFR mutation-positive non-small-cell lun

33 uraging antitumour activity in patients with MET-amplified, EGFR mutation-positive, advanced NSCLC, w

34 contributes to its capacity to downregulate MET and inhibit human tumor cell proliferation.

35 ergo a mesenchymal to epithelial transition (MET) and re-organise into acini-like structures, reminis

36 MET proto-oncogene receptor tyrosine kinase (MET) and Wnt/beta-catenin signaling pathways has been ob

37 ontrol) were packed in multilayer metalized (MET), and ethylene vinyl alcohol (EVOH) based pouches an

38 or receptor (EGFR) and proto-oncogene c-Met (MET), and shunts their trafficking into late endosomes a

39 ihood that their elimination target has been met, and where to invest in additional sampling.

40 ults show that if the Paris Agreement is not met, Antarctica's long-term sea-level contribution will

41 5.1%, P = .001), as did patients who did not meet any criteria but were nonetheless cultured (23.9% v

42 Results of the meeting are presented in this concise review, which reca

43 racers is limited; thus, (18)F-FET and (11)C-MET are preferred when available.

44 Both primary endpoints were met: ASAS40 at week 16 (ixekizumab Q4W: 34 [35%] of 96,

45 Additionally, br-met-associated CNS-myeloid exhibited downregulation of C

46 ite populations (e.g., annual membership and meeting attendance costs).

47 rvival as CA TCMR when biopsy specimens also met Banff criteria for TCMR and/or AMR.

48 Tumour cells frequently utilize glutamine to meet bioenergetic and biosynthetic demands of rapid cell

49 ch the heart cannot pump blood to adequately meet bodily demands, resulting in high mortality despite

50 Thirteen patients met both inclusion and exclusion criteria, and their tis

51 g relieved immune suppression and reduced br-met burden.

52 Primary success was met by 73%.

53 enging applications which can not be readily met by conventional FT-IR spectroscopy.

54 de excellent outcomes in selected cases that meet certain corneal topographic criteria.

55 g-based disease progression for patients who met certain criteria.

56 D); in eyes with toric IOL implantation that met certain inclusion criteria, 80%, 84%, and 69% of eye

57 ograms for invading pathogens must initially meet challenges that include low rates of occurrence on

58 ent requires mechanoelectrical transduction (MET) channels at tips of hair-cell stereocilia.

59 l to 6 hours and determined whether patients met complete pediatric acute respiratory distress syndro

60 s essential role in tensioning the hair cell MET complex.

61 hair bundles and proper trafficking of known MET components Protocadherin 15a (Pcdh15a), Lipoma HMGIC

62 institutional change that was developed at a meeting convened by DORA and the Howard Hughes Medical I

63 early changes were 2.5 times more likely to meet COPD diagnostic criteria at follow-up.Conclusions:

64 tious mononucleosis (IM) annually, and 9-12% meet criteria for ME/CFS six months later.

65 predisposition genes compared with women not meeting criteria (9.0% v 3.5%; P < .001).

66 recently published Classification of Atrophy Meeting criteria as sharply demarcated hyperreflective r

67 2MI, or myocardial injury (troponin rise not meeting criteria for myocardial infarction [MI]) using t

68 mean of 2.2 days compared with patients who met criteria but did not have the alert fire (8.0 vs 5.8

69 ly one-third of heterosexual individuals who met criteria for a past-year alcohol use disorder did.

70 5%) and gay or lesbian (51%) individuals who met criteria for a past-year alcohol use disorder had a

71 milar differences were found among those who met criteria for a past-year tobacco use disorder.

72 240 eyes in 203 patients met criteria for analysis (38 eyes were lost to follow u

73 ompleted the final pain assessment, 74 (41%) met criteria for chronic postsurgical pain (CPSP), that

74 Osocimab given postoperatively met criteria for noninferiority compared with enoxaparin

75 osocimab 0.6 mg/kg, 1.2 mg/kg, and 1.8 mg/kg met criteria for noninferiority compared with enoxaparin

76 ed patients with logopenic PPA and those who met criteria for PPA but not a specific subtype.

77 the preoperative 1.8-mg/kg dose of osocimab met criteria for superiority compared with enoxaparin fo

78 val is critical for using these organisms to meet current and future demands for food and other plant

79 n living in areas where air quality does not meet current WHO guidelines, combined with the knowledge

80 pleasant organoleptic characteristics, thus meet customers' requirements.

81 tial dietary restriction or with bacterial l-Met-degrading enzymes exerts potent antitumor effects.

82 s and halt species extinctions are not being met despite decades of conservation action.

83 he rational and parameters employed to study MET devices and electroactive microorganisms.

84 ne clinical evaluation, and 17 of 51 (33.3%) met diagnostic criteria for CPVT.

85 Smartphone-based fundus imaging can meet DR screening requirements in an outreach setting; h

86 When the shell is closed, the 2 valve edges meet each other in a commissure that forms a continuum w

87 This study did not meet either of its coprimary endpoints.

88 strated that systemic restriction of serum l-Met, either via partial dietary restriction or with bact

89 nd seven clinical (n = 164 patients) studies met eligibility.

90 These differences failed to meet established thresholds for a clinically meaningful

91 MET exon 14 alteration defines a molecular subgroup of N

92 ted therapy in people with lung cancers with MET exon 14 alterations and adds to an expanding list of

93 g from complications is useful, M&M does not meet expectations for system-wide improvement.

94 Veritor met FDA emergency use authorization (EUA) acceptance cri

95 In total, 407 patients met final inclusion criteria (332 adults, 75 children).

96 Hence, beyond GWASs, this meeting focused on gene regulatory mechanisms, the singl

97 The required information size was met for our primary outcome and trial sequential analysi

98 w power, long range communication systems to meet growing demand for Internet of Things applications.

99 The receptor kinase c-MET has emerged as a target for glioblastoma therapy.

100 ions that compared 7.5, 15.0, 22.5, and 30.0 MET hours/week to no leisure-time physical activity, and

101 fter randomization, the primary endpoint was met in 6 (12%) DJBL patients and 3 (10%) controls (P = 0

102 e tumor samples, implicating a novel role of MET in beta-catenin-mediated transcription.

103 nternational academic and government experts met in March 2019 to frame the initial inquiry, which wa

104 Three criteria should be met in order to be considered a successful outcome: firs

105 The primary objective was met in six of the nine patients at 12 months follow-up,

106 prespecified threshold for activity was not met in the trial, we believe that the preliminary antitu

107 A total of 274 patients meeting inclusion and exclusion criteria were identified

108 .6%) had asymmetric, bilateral amblyopia; 98 met inclusion and exclusion criteria.

109 Of 128 enrolled, 100 participants met inclusion criteria (mean age, 48.6 years; 41 men).

110 Among 1,889,032 Medicare beneficiaries who met inclusion criteria 560,744 (n = 29.7%) individuals h

111 A total of 35 studies met inclusion criteria and form the evidence base, inclu

112 went esophagectomy between 1991 and 2017 who met inclusion criteria and were contactable, responded t

113 In total, 1,710 samples met inclusion criteria.

114 Indiana University between 1990 and 2016 who met inclusion criteria.

115 ynthesized data from full-text articles that met inclusion criteria.

116 Of 201 patients evaluated, 163 met inclusion criteria: 116 anomalous right CA (71%), 25

117 1 individuals screened (11/2016-7/2017), 200 met inclusion criteria; 58% injected drugs and 31% share

118 n crop breeding and domesticate new crops to meet increasing human demands.

119 c-MET inhibition causes profound metabolic reprogramming t

120 nes a molecular subgroup of NSCLCs for which MET inhibition with crizotinib is active.

121 expression of PGC1alpha in the context of c-MET inhibition.

122 This study demonstrates that MEKi plus MET inhibitor may delay or prevent a novel mechanism of

123 ents with advanced HCC treated by a specific MET inhibitor.

124 Accordingly, HER2 blockers, but not c-MET inhibitors, are paradoxically effective at restraini

125 tation of this project is that our consensus meeting involved a small number of individuals, the majo

126 at chemoattractant signaling between Hgf and Met is required for vagus innervation of the pharyngeal

127 However, to meet its full potential, several improvements to REDCRAF

128 ion design has not seen generative models to meet its potential to accelerate resistance-overcoming d

129 easing GHG intensity should be considered in meeting its commitment to emission reductions.

130 The study met its primary endpoint: the fixed-dose combination of

131 We have found that eDNA methods meet legal standards for being admissible as evidence in

132 of previous drug of abuse vaccines that have met limited success in the past.

133 res adequate oxygen and nutrient delivery to meet local metabolic demand.

134 When these challenges are met, machine learning promises a future of rigorous, out

135 factor receptor (EGFR) and proto-oncogene c-Met (MET), and shunts their trafficking into late endoso

136 troller that can self-adjust in real-time to meet metabolic needs.

137 ety-like and depression-like behavior in Het-Met mice, but not in WT mice.

138 s markedly different between WT mice and Het-Met mice.

139 mapping is routinely used to select vessels meeting minimal threshold diameters for surgical arterio

140 high-level MET amplification and activating MET mutations or fusions are all now known to be drivers

141 These results establish MET(N375S) as a biologically distinct and clinically act

142 ining in vivo and in vitro models expressing MET(N375S).

143 Of 3,907 women, 1,872 (47.9%) meeting NCCN criteria were more likely to carry a pathog

144 of educational attainment and contraceptive met need.

145 In total, 223 of 266 participants met neuropathological diagnostic criteria for CTE.

146 me of rump steak was the best combination to meet nutritional expectations.

147 was selected as the topic of the 27th Annual Meeting of the European Charcot Foundation.

148 Interestingly, the occupancy of MET on the Myc promoter also appeared in the compound mo

149 ned work groups to a 20-minute participatory meeting once per week for six weeks, in which the superv

150 ypes at TNFAIP3, 9 have at least one variant meeting one or both of these criteria, 5 of which are fu

151 ide-supported materials, this requirement is met only at the perimeters of metal nanoparticles.

152 Absolute and relative risks of meeting or exceeding 60 dBA differ considerably across o

153 CT, the proportion with ILD events (endpoint met or radiographic ILA progression) was calculated.Meas

154 on biopsies, those with i-IFTA >= 2, without meeting other criteria for CA TCMR had similar postbiops

155 nic crops represents a promising strategy to meet our demands for specialized plant oils with industr

156 We identified 41 studies that met our inclusion criteria involving 112,034 patients in

157 utional study, 162 patients (7-18 years old) met our inclusion criteria with a mean age of 13.4 years

158 ms and identified 1928 articles, of which 37 met our inclusion criteria.

159 A total of 111 articles met our inclusion criteria.

160 ectronic health records to identify patients meeting pediatric acute respiratory distress syndrome ox

161 Children meeting pediatric acute respiratory distress syndrome ox

162 tients were identified, of which 577 (52.9%) met PIVOT criteria.

163 ned reductions in soil inorganic N could not meet plant N demand.

164 crosses the leaf surface and assimilates to meet plant nutrient demands.

165 is unclear whether foliar P applications can meet plant nutrient demands.

166 ient had no evidence of cardiac disease, but met possible ARVC diagnosis with one major criterion (th

167 Met-predictor was tested on two independent test sets, w

168 s these problems, we propose a novel method, Met-predictor, to predict methylation sites and methylat

169 was stopped early and no treatment strategy met prespecified criteria for statistical superiority, p

170 based microfluidics for single cell analysis met problems.

171 l10-mediated vicious cycle, cultivating a br-met-promoting, immune-suppressive niche.

172 e of aberrant hepatocyte growth factor (HGF)/MET proto-oncogene receptor tyrosine kinase (MET) and Wn

173 All programs met queueing time and distance indicators, did not meet

174 re, opportune, or delayed based on when they met readiness-to-wean criteria.

175 still elusive for most of them including the MET receptor.

176 risk estimates, the research community must meet robust methodological and communication standards.

177 l to play a major role in helping California meet SB 1383 while reducing state emissions by -6.3 +/-

178 ponse syndrome-first compared with those who met Sequential Organ Failure Assessment-first (odds rati

179 at experimentally altering the timing of Hgf/Met signaling is sufficient to redirect axon targeting a

180 controls the spatiotemporal dynamics of Hgf/Met signaling to coordinate axon targeting with the deve

181 HGF/MET signaling was elevated in the MEKi-resistant model.

182 transgenic mouse line that sustains cortical MET signaling.

183 e human hepatocyte growth factor receptor (c-MET) signaling pathway is dysregulated in several malign

184 flexibility to tailor microbial membranes to meet specific needs.

185 ht for 8 outcomes), these findings would not meet statistical significance (all P > .003).

186 Secukinumab did not meet statistical significance for superiority versus ada

187 the top 12 NDD genes with damaging DNVs that met statistical significance after Bonferroni correction

188 Of 101 included trials, 12 met statistical significance for their main endpoint, fi

189 Four hundred three patients met study criteria: 313 (78%) without adjuvant therapy a

190 A total of 37,163 individuals met study inclusion criteria; 10.4% were tested by IGRA.

191 The Val to Met substitution in the S4-S5 loop induced a larger incr

192 ly, the empowering of regulatory subsets has met success in mitigating autoimmune diseases.

193 there exist few solid additives reported to meet such expectations.

194 ion of FA and glycogen storage regardless of Met supply.

195 We report that MET surface expression is reduced by MARCH1, 4, or 8-med

196 l mortality were 39% greater in patients who met systemic inflammatory response syndrome-first compar

197 cular pressure (IOP), the proportion of eyes meeting target IOP, and change in visual acuity since th

198 nterval and safety of FME using EMI-137, a c-Met-targeted fluorescent peptide, in a population at hig

199 decreases the level of eIF2-GTP-Met-tRNA(i)(Met) ternary complexes.

200 ercent of optimal solutions starting in 1980 meet the 2(or 1.5) degree target, 5(or 0)% of 2020 simul

201 femoral access in patients with less time to meet the 90-minute quality metric.

202 Laryngeal cancer (LC) patients who meet the age and smoking criteria of the U.S. Preventive

203 ts control light-dependent FAS regulation to meet the cellular demand for acyl chains.

204 ding how macrophages shape their proteome to meet the challenge of infection.

205 To meet the challenge, we report a nanoprinting technique t

206 ochondria can switch metabolic phenotypes to meet the challenges of high energy demand and macromolec

207 m and development must be closely coupled to meet the changing physiological needs of each stage in t

208 enetic testing is imperative in patients who meet the current testing criteria in order to identify r

209 Six patients did not meet the definition of BCG-unresponsive non-muscle-invas

210 degree target, 5(or 0)% of 2020 simulations meet the goals.

211 ve as an intriguing class of 3D materials to meet the growing demands for flexible, foldable, biocomp

212 To meet the increasing demand for data communication bandwi

213 resection, although this difference did not meet the MID for the GIQLI.

214 .7, P = 0.018), which approached but did not meet the minimum important difference of 10.

215 ion of protein biomarkers in FFPE samples to meet the need of daily clinical practice, especially for

216 ism by which cellular proteostasis adapts to meet the needs of a changing growth environment.

217 e synthesis of shaped metal nanoparticles to meet the precise needs of emerging applications requires

218 More recently, to meet the requirement of new types of displays such as or

219 ated to unreviewed records in UniProtKB that meet the same selection criteria, most of which do not h

220 nal patterning methods cannot simultaneously meet the stringent requirements of resolution, throughpu

221 A preparation that does not meet the sufficient dose can be cultured until this is r

222 be developed as we enter the last decade to meet the Sustainable Development Goals (SDGs) and target

223 s required in sugar content and pack size to meet the targets were 5.2 g per 100 g/mL (26%) and 61.2

224 The sampling results that meet the test accuracy requirements suggest the possibil

225 alysis pipeline (M2IA) has been developed to meet the urgent needs for tools that can effectively int

226 Identification of the group of patients meeting the criteria of a severe multiple trauma (polytr

227 l as Google Scholar, resulted in six studies meeting the criteria of primary qualitative research pub

228 orms, however, is key to reducing stigma and meeting the demand for contraception of young women.

229 Studies were screened with N = 11 meeting the inclusion/exclusion criteria.

230 s to individuals is not a viable approach to meeting the mental health needs of a population.

231 D in women, women showed a lower tendency of meeting the PA Guidelines.

232 colonies under new climate change scenarios meeting the Paris Agreement objectives using a climate-d

233 ng codon-optimized human RPGR (AAV8-coRPGR), meeting the pre-specified primary endpoint.

234 e was 90.6% (lower confidence limit, 89.0%), meeting the prespecified performance goal of 85.8%.

235 This community-driven approach is a key to meeting the pressing needs of science and society in the

236 of pairs of brothers without medical history meeting the selection criteria of young (age <35 years)

237 feasibility, i.e., ~1/3 of products already meeting the target, and alignment with existing, relevan

238 from microscale to macroscale production in meeting the targeted 10% STH.

239 present Metage2Metabo (M2M) a resource that meets the need for de novo functional screening of genom

240 chine learning model identified patients who met the composite endpoint with an AUC of 0.90, the GBS

241 5.7-14]; 20 girls [34%]) were identified who met the criteria for PIMS-TS.

242 of participants had phenotypic features that met the diagnostic criteria for more than one syndrome.

243 A preplanned interim analysis met the efficacy criterion for early closure after recru

244 Response was assessed in all patients who met the eligibility criteria and who received at least 8

245 , an estimated 0.6% (95% CI, 0.5%-0.6%) also met the guideline threshold for antihypertensive therapy

246 Most health centers met the Healthy People 2020 baseline, but opportunities

247 were selected for a full-text review, and 13 met the inclusion criteria and were assigned a quality-o

248 patients with acute neurologic symptoms, 73 met the inclusion criteria and were included (23.7%): th

249 A total of twelve studies met the inclusion criteria and were included in the revi

250 Twenty articles met the inclusion criteria for this assessment and were

251 The data of the women who met the inclusion criteria were linked to the data of th

252 Among 2,084 patients, 1,289 met the inclusion criteria.

253 Eighty-four eyes (55 patients) met the inclusion criteria.

254 rimary studies of multifaceted interventions met the inclusion criteria.

255 rticles were assessed in full and 37 studies met the inclusion criteria.

256 We included 18 128 patients who met the inclusion criteria.

257 hundred five eyes of 986 AREDS2 participants met the inclusion criteria; of these, 977 participants (

258 re significantly worse than for patients who met the Kidney Disease: Improving Global Outcomes urine

259 ka virus disease cases were included if they met the national surveillance case definition, had illne

260 The modified method was validated and met the performance criteria required by the EU Regulati

261 e interval, 0.87-2.82; 1-sided P = .068) and met the prespecified 1-sided alpha of 0.10.

262 At week 12, the etrasimod 2 mg group met the primary and all secondary endpoints.

263 Next, we determined how many of the patients met the same criteria at other points in time.

264 SO palsy; 54 congenital and 11 acquired, who met the study criteria and were classified into 3 groups

265 ther organisms, when the two pronuclei first meet, the parental genomes are separated by four pronucl

266 oproteins hijack the host cell metabolism to meet their own energy demands and how this may contribut

267 nt cooperates or competes with each other to meet their own metabolic demands during infection has th

268 research develops innovative technologies to meet these challenges.

269 is unknown whether neural confidence signals meet these criteria.

270 s with manufacturing dates prior to 2013 are meeting these bioefficacy standards.

271 How the SAC meets these potentially antagonistic requirements is unc

272 ion-making) demands innovative approaches to meet this ambitious goal.

273 flow cytometry and immunohistochemistry, to meet this need.

274 explain how executable computational models meet this need.

275 To meet this unmet medical need, we aimed to elucidate an a

276 Caulobacter crescentus is a species that has met this need effectively, as its dimorphic lifestyle sh

277 ssess final energy and emission pathways for meeting three essential and energy-intensive dimensions

278 This challenge might be met through canonical correlation analysis designed to m

279 The US National Cancer Institute convened a meeting to review previous recommendations and existing

280 ole for Rac1 in mediating a PI3K-independent MET-to-mTOR pathway and suggest alternative or combined

281 out safety concerns around using aspirin and meeting trial eligibility criteria.

282 ormation and decreases the level of eIF2-GTP-Met-tRNA(i)(Met) ternary complexes.

283 a defining feature distinguishing different met-types.

284 The activity of MET tyrosine kinase inhibitors varies by MET alteration

285 ubiquitination and that emibetuzumab-induced MET ubiquitination contributes to its capacity to downre

286 ggest that this support reduces mortality by meeting urgent material needs, but also that sharing gen

287 Younger patients less frequently met very high-risk criteria for intensive secondary prev

288 s were recorded for consecutive visits after meeting vision criteria (maximum of 16 visits).

289 cope demonstrated that the Callascope camera meets visual requirements for cervical imaging.

290 XVth Banff Conference on Allograft Pathology meeting was held on September 23-27, 2019, in Pittsburgh

291 eueing time and distance indicators, did not meet water quantity indicators, and inconsistently met w

292 ater quantity indicators, and inconsistently met water quality indicators.

293 When the rule is met, we added the mandatory use of fortified topical ant

294 resented an abstract at the ASCO 2018 Annual Meeting were obtained and matched to payment data in OP.

295 syndrome as a differential diagnosis when we meet with the adult patient of recurrent fever.

296 The lack of transferability is often met with a largely empirical approach to optimizing cata

297 translate this success to solid tumors have met with limited success.

298 Unfortunately, such methods have thus far met with limited success.

299 The primary end point was met, with an sCR rate of 60% after 8 cycles.

300 The primary end point was met, with the ORR reaching 60.9% (95% CI, 45.4% to 74.9%

301 ients (43%) in this SOC study would not have met ZUMA-1 eligibility criteria because of comorbidities